POWERING THE FUTURE OF IMMUNE MEDICINE. Logo (WIPO, 09.07.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke POWERING THE FUTURE OF IMMUNE MEDICINE. wurde als Wortmarke am 09.07.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1617211 |
| Länder | 
|
| Basismarke |
Nr. 90459476,
11. Januar 2021
|
| Anmeldedatum | 09. Juli 2021 |
| Ablaufdatum | 09. Juli 2031 |
Markeninhaber
1551 Eastlake Avenue E, Suite 200
Seattle WA 98102
US
Seattle WA 98102
US
Markenvertreter
310 East 4500 South, Suite 400
Salt Lake City UT 84107
US
Waren und Dienstleistungen
42
Providing medical diagnostic assays and diagnostic and
prognostic testing for medical research purposes of residual
disease, and the analysis, evaluation, and reporting of
those test results to help healthcare professionals for
research purposes; development of new technology for others
in the field of biotechnology; DNA analysis services for
scientific research purposes; genetic testing for scientific
research purposes; genome amplification; genotyping services
for research or analysis purposes; laboratory research in
the field of immune sequencing; medical and scientific
research in the field of cancer treatment and diagnosis;
medical and scientific research in the field of immune
sequencing; providing laboratory research services in the
field of gene expression, namely, cancer biology; providing
medical and scientific research information in the field of
clinical trials; providing medical and scientific research
information in the fields of pharmaceuticals and genetics;
research and development in the pharmaceutical and
biotechnology fields; research, development, engineering and
testing services in the fields of immunopharmaceuticals and
vaccines; scientific research in the field of genetics and
genetic engineering; DNA screening for scientific research
purposes; medical research; consulting services in the
fields of biotechnology, pharmaceutical research and
development and genetic science; consulting services in the
fields of biotechnology, pharmaceutical research and
development, laboratory testing, diagnostics, and
pharmacogenetics; custom design and development of chemical
reagents and biochemical assays; development of new
technology for others in the field of immunotherapy;
laboratory research in the field of immunotherapy, oncology,
hematology, auto-immune disorders, and infectious diseases;
medical and scientific research in the field of
immunotherapy; medical laboratory services
44
Providing medical diagnostic assays and diagnostic and
prognostic testing for treatment purposes of residual
disease, and the analysis, evaluation, and reporting of
those test results to help healthcare professionals
determine a patient's clinical diagnosis, the effectiveness
of patient treatments, and to revise future treatments
accordingly; medical services; consulting services in the
field of medical diagnostic and prognostic testing; medical
analysis services; medical analysis services for diagnostic
and prognostic testing and treatment purposes; providing
medical diagnostic and prognostic testing services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 03. April 2023 | 2023/14 Gaz | KR | Ablehnung |
| 31. März 2023 | 2023/17 Gaz | SG | Ablehnung |
| 31. Januar 2023 | 2023/7 Gaz | ID | Ablehnung |
| 27. Januar 2023 | 2023/5 Gaz | CA | Ablehnung |
| 22. Dezember 2022 | 2022/52 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. November 2022 | 2022/44 Gaz | KR | Ablehnung |
| 21. Oktober 2022 | 2022/42 Gaz | NO | Ablehnung |
| 21. September 2022 | 2022/39 Gaz | BR | Ablehnung |
| 21. September 2022 | 2022/39 Gaz | ID | Ablehnung |
| 04. September 2022 | 2022/37 Gaz | EG | Ablehnung |
| 01. September 2022 | 2022/36 Gaz | EM | Ablehnung |
| 08. August 2022 | 2022/32 Gaz | IL | Ablehnung |
| 01. August 2022 | 2022/31 Gaz | MX | Ablehnung |
| 27. Juli 2022 | 2022/31 Gaz | MY | Ablehnung |
| 01. Juli 2022 | 2022/28 Gaz | CO | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. Juni 2022 | 2022/25 Gaz | JP | Ablehnung |
| 12. Mai 2022 | 2022/20 Gaz | NO | Ablehnung |
| 06. April 2022 | 2022/14 Gaz | CN | Ablehnung |
| 25. März 2022 | 2022/12 Gaz | NZ | Ablehnung |
| 23. März 2022 | 2022/12 Gaz | Löschung | |
| 08. März 2022 | 2022/11 Gaz | CO | Ablehnung |
| 28. Februar 2022 | 2022/9 Gaz | TR | Ablehnung |
| 04. Februar 2022 | 2022/6 Gaz | SG | Ablehnung |
| 25. Januar 2022 | 2022/5 Gaz | IL | Ablehnung |
| 05. Januar 2022 | 2022/1 Gaz | AU | Ablehnung |
| 15. November 2021 | 2021/47 Gaz | GB | Ablehnung |
| 29. Oktober 2021 | 2021/45 Gaz | EM | Ablehnung |
| 18. Oktober 2021 | 2021/43 Gaz | IN | Ablehnung |
| 09. Juli 2021 | 2021/38 Gaz | US | Eintragung |
ID: 141617211